Consent to the Distribution of Changed Medicines Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the changed medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Megestrol acetate 40 mg/ mL in 240 mL Suspension (oral) U S Pharmaceutical Group, Evansville, Indiana, United States of America Megostat Lisinopril 5 mg, 10 mg, 20 mg Tablets Laboratories Merck Sharp & Dohme-Chibret (Mirabel Plant), Riom, France and Merck Sharp & Dohme (Aust) Pty Limited, South Granville, New South Wales, Australia Prinivil Cyclosporin A 25 mg, 100 mg Capsules Sandoz Pharma Limited, Basle, Switzerland Sandimmun Cyclosporin A 100 mg per mL in 50 mL Solution (oral) Sandoz Pharma Limited, Basle, Switzerland Sandimmun Lisinopril dihydrate 5 mg, 10 mg, 20 mg, 40 mg, 80 mg Tablets Zeneca Pharmaceuticals, Macclesfield, Cheshire, England Zestril Amantadine hydrochloride 100 mg Capsule R P Scherer GmbH, Eberbach, Germany Symmetrel Simvastatin 5 mg, 10 mg, 20 mg, 40 mg Tablets Merck & Co Inc., West Point, Pennsylvania, United States of America and Merck Sharp & Dohme (Aust) Pty Limited, South Granville, New South Wales, Australia Zocor Dated this 12th day of September 1995. KAREN O. POUTASI, Director-General of Health, pursuant to delegation given by the Minister of Health on 25 June 1993.